Edition:
India

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.96USD
23 Aug 2019
Change (% chg)

$-0.03 (-3.18%)
Prev Close
$0.99
Open
$0.98
Day's High
$0.99
Day's Low
$0.95
Volume
45,578
Avg. Vol
403,761
52-wk High
$3.87
52-wk Low
$0.66

Latest Key Developments (Source: Significant Developments)

Biocept Q2 Revenue Rose 45% To $1.2 Mln
Tuesday, 13 Aug 2019 

Aug 12 (Reuters) - Biocept Inc ::BIOCEPT REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 REVENUE ROSE 45 PERCENT TO $1.2 MILLION.QTRLY LOSS PER SHARE $0.38.  Full Article

Biocept Q3 Loss Per Share $2.42
Wednesday, 14 Nov 2018 

Biocept Inc ::BIOCEPT REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $2.42.Q3 REVENUE $762,000 VERSUS I/B/E/S VIEW $948,000.Q3 EARNINGS PER SHARE VIEW $-2.02 -- THOMSON REUTERS I/B/E/S.CASH AND CASH EQUIVALENTS AS OF SEPTEMBER 30, 2018 WERE $9.0 MILLION, COMPARED WITH $2.1 MILLION AS OF DECEMBER 31, 2017.  Full Article

Biocept Announces Pricing Of $2.5 Mln Registered Direct Offering
Friday, 21 Sep 2018 

Sept 21 (Reuters) - Biocept Inc ::BIOCEPT ANNOUNCES PRICING OF $2.5 MILLION REGISTERED DIRECT OFFERING PRICED AT MARKET.BIOCEPT INC - COMBINED PURCHASE PRICE FOR ONE SHARE OF COMMON STOCK AND EACH WARRANT WILL BE PRICED AT $3.285.  Full Article

Biocept Q1 Loss Per Share $0.11
Wednesday, 16 May 2018 

May 15 (Reuters) - Biocept Inc ::BIOCEPT REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.11.Q1 REVENUE $800,000 VERSUS $1.7 MILLION.  Full Article

Biocept Reports Q4 Loss Of $0.18 Per Share
Thursday, 29 Mar 2018 

March 28 (Reuters) - Biocept Inc ::BIOCEPT REPORTS 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.18.‍REVENUES FOR Q4 2017 WERE $1.0 MILLION, COMPARED WITH $1.3 MILLION FOR Q4 OF 2016​.‍CASH AND CASH EQUIVALENTS WERE $2.1 MILLION AS OF DEC 31, 2017, COMPARED WITH $4.6 MILLION LAST YEAR.  Full Article

Biocept And Thermo Fisher Scientific Enter Into Technology And Commercial Collaboration
Wednesday, 28 Mar 2018 

March 28 (Reuters) - Biocept Inc ::BIOCEPT AND THERMO FISHER SCIENTIFIC ENTER INTO TECHNOLOGY AND COMMERCIAL COLLABORATION.BIOCEPT INC - ENTERED INTO A NON-BINDING MEMORANDUM OF UNDERSTANDING WITH THERMO FISHER SCIENTIFIC, INC. TO COLLABORATE TOGETHER COMMERCIALLY​.BIOCEPT - P‍LAN TO VALIDATE THERMO FISHER'S ONCOMINE NEXT-GENERATION SEQUENCING LIQUID BIOPSY PANELS IN BIOCEPT'S CLIA-CERTIFIED LABORATORY​.  Full Article

Biocept Inc Says Signed An In-Network Provider Agreement With Wellmark Inc
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Biocept Inc ::BIOCEPT INC - HAS SIGNED AN IN-NETWORK PROVIDER AGREEMENT WITH WELLMARK INC.  Full Article

Sabby Management LLC Reports A 9.20 Pct Passive Stake In Biocept
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Biocept Inc ::SABBY MANAGEMENT LLC REPORTS A 9.20 PCT PASSIVE STAKE IN BIOCEPT INC <<>> AS OF DEC 5 - SEC FILING.  Full Article

Biocept announces pricing of public offering of up to 4,925,936 shares of common stock
Wednesday, 6 Dec 2017 

Dec 6 (Reuters) - Biocept Inc ::BIOCEPT ANNOUNCES PRICING OF PUBLIC OFFERING OF UP TO 4,925,936 SHARES OF COMMON STOCK.BIOCEPT - ‍PRICED BEST EFFORTS REGISTERED PUBLIC OFFERING OF UP TO 4.9 MILLION SHARES OF CO'S COMMON STOCK AT PRICE TO PUBLIC OF $0.68/SHARE​.  Full Article

Biocept files for offering $10 mln of shares of co's common stock and warrants
Saturday, 18 Nov 2017 

Nov 17 (Reuters) - Biocept Inc :Biocept Inc files for offering $10 million of shares of co's common stock and warrants - SEC Filing.Biocept - shares of co's common stock and warrants are immediately separable and will be issued separately, but will be purchased together in the offering.  Full Article